RxDoctor Payments Data

Julianne John

Psychiatric/Mental Health · Milwaukee, WINPI 1689292856

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 97.4% of the total across 78 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 13 manufacturers reported payments, led by Teva Pharmaceuticals USA, Inc. at 27.0% of the total. 2025 is the largest year on record at $1,899, more than ten times the $12 reported in 2021. Among psychiatric/mental health clinicians in WI with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$4,304in general payments, 2019–2025

Across 78 payments — averaging $55.18 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Teva Pharmaceuticals USA, Inc.$1K
  • Johnson & Johnson$810
  • AbbVie$684
  • Axsome Therapeutics, Inc.$512
  • Alkermes, Inc.$342
  • Neurocrine Biosciences, Inc.$332
  • plus $462 from 7 others

What the payments were for

  • Food & beverage$4,19397%
  • Education$1113%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$4,304 in reported general payments places this provider in the 90th percentile of 384 psychiatric/mental health providers in Wisconsin.

See all psychiatric/mental health providers in Wisconsin

Medicare billing

Part B allowed, 2024
$7,365
Medicare patients
28
Services billed
100

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
TrintellixVortioxetine Hydrobromide12$5,773
Venlafaxine Hcl ErVenlafaxine Hcl143$3,431
Duloxetine Hcl103$3,241
Quetiapine Fumarate137$2,456
Ziprasidone Hcl41$1,643
Hydroxyzine Hcl107$1,539
Ramelteon13$1,445
Mirtazapine86$1,414
Aripiprazole42$1,369
Divalproex Sodium ErDivalproex Sodium35$1,220
Bupropion XlBupropion Hcl52$1,017
Lurasidone Hcl36$967
Sertraline Hcl104$951
Trazodone Hcl112$809
Haloperidol Decanoate13$729

Paid to pharmacies, not to this prescriber.

Other psychiatric/mental health in Milwaukee

See the full list for Wisconsin

Where these figures come from

Is this you, or does something look wrong? →